Voya Investment Management LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $49,903 - $79,343	-35,902 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $11,238 - $22,596	11,956 Added 49.93%	35,902 $45,000
Q2 2020 Aug 14, 2020	SELL	$4.79 - $8.39 $42,908 - $75,157	-8,958 Reduced 27.22%	23,946 $201,000
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $7,702 - $16,143	2,239 Added 7.3%	32,904 $172,000
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $26,413 - $34,725	6,157 Added 25.12%	30,665 $167,000
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $17,635 - $20,841	2,672 Added 12.24%	24,508 $170,000
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $12,896 - $15,202	1,954 Added 9.83%	21,836 $155,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $114,321 - $154,085	19,882	19,882 $142,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $946M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.